{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:09:00Z","timestamp":1789186140143,"version":"build-2803163510"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.8114-26","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:11:26Z","timestamp":1788819086000},"source":"Crossref","is-referenced-by-count":0,"title":["Life-long management of atrial fibrillation in a patient with hypertrophic obstructive cardiomyopathy following alcohol septal ablation: A10-year follow-up case report"],"prefix":"10.2169","author":[{"given":"Keitaro","family":"Akita","sequence":"first","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Naruse","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sano","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hirano","sequence":"additional","affiliation":[{"name":"First Department of Surgery, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Maekawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sorajja P, Ommen SR, Holmes DR Jr, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation 126: 2374-2380, 2012.","DOI":"10.1161\/CIRCULATIONAHA.111.076257"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Veselka J, Krej\u010d\u00ed J, Toma\u0161ov P, et al. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with the general population. Eur Heart J 35: 2040-2045, 2014.","DOI":"10.1093\/eurheartj\/eht495"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Liebregts M, Vriesendorp PA, Mahmoodi BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. JACC Heart Fail 3: 896-905, 2015.","DOI":"10.1016\/j.jchf.2015.06.011"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Akita K, Sato R, Anzai A, et al. Multiple-branch alcohol septal ablation is associated with reduced cardiovascular events: insights from a Trans-Pacific multicentre registry. CJC Open 7: 1324-1331, 2025.","DOI":"10.1016\/j.cjco.2025.07.003"},{"key":"5","unstructured":"5. Japanese Circulation Society Joint Working Group. JCS\/JHFS 2018 guideline on diagnosis and treatment of cardiomyopathies. Circ J 85: 1590-1689, 2021."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kasahara S, Sakata Y, Nochioka K, et al. Conversion formula from B-type natriuretic peptide to N-terminal proBNP values in patients with cardiovascular diseases. Int J Cardiol 280: 184-189, 2019.","DOI":"10.1016\/j.ijcard.2018.12.069"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yokoyama Y, Shimoda T, Shimada YJ, et al. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis. Eur J Cardiothorac Surg 63: ezad043, 2023.","DOI":"10.1093\/ejcts\/ezad043"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Moss TJ, Zipse MM, Krantz MJ, et al. Incidence of atrial fibrillation following alcohol septal ablation for hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol 21: 443-449, 2016.","DOI":"10.1111\/anec.12335"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sun D, Schaff HV, Nishimura RA, et al. Patient-reported atrial fibrillation after septal myectomy for hypertrophic cardiomyopathy. Ann Thorac Surg 113: 1918-1924, 2022.","DOI":"10.1016\/j.athoracsur.2021.08.081"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Weissler-Snir A, Adler A, Fourey D, et al. Left atrial remodeling postseptal myectomy for severe obstructive hypertrophic cardiomyopathy: analysis by two-dimensional speckle-tracking echocardiography. Echocardiography 36: 108-115, 2019.","DOI":"10.1111\/echo.14226"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagueh SF, Lakkis NM, Middleton KJ, et al. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 34: 1123-1128, 1999.","DOI":"10.1016\/S0735-1097(99)00341-1"},{"key":"12","unstructured":"12. Sugrue A, Bandyopadhyay D, Tajik AJ, et al. Catheter ablation of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart Rhythm 20: 1160-1169, 2023."},{"key":"13","unstructured":"13. Gaita F, Di Donna P, Olivotto I, et al. Long-term clinical results of atrial fibrillation ablation in patients with hypertrophic cardiomyopathy. Circulation 116: 1961-1967, 2007."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ezzeddine FM, Agboola KM, Hassett LC, et al. Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis. Europace 25: 1-12, 2023.","DOI":"10.1093\/europace\/euad256"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ommen SR, Ho CY, Asif IM, et al. 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy. Circulation 149: e1239-e1311, 2024.","DOI":"10.1161\/CIR.0000000000001250"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8114-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:29:54Z","timestamp":1789183794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_8114-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":15,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8114-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"8114-26"}}